I find it useful to look at some attributes to help understand this situation. They not always mutually exclusive.
Pre-market or post-market
The dividing line is a complete DoC and CE Mark on the device. In Article 120 I take the dividing line as the NB audit to extend the device certificate.
QMS or Device
Often there is a QMS requirement that is then applied to every device. For example, the QMS requires a Clinical Evaluation System. Each device (or device type) will need a clinical evaluation plan and a clinical evaluation report.
Article 120 or Full MDR
This depends on your ability to engage an MDR Notified Body, complete all of the preparations, and pass the NB's audit. If not, then you would hope to implement Article 120.
I infer from your question that you are asking about the Article 120 path.
This is a hybrid system, so you will need a QMS that satisfies the MDD except in some specific areas. The three obvious areas are from Chapter VII and the associated annexes for post-market surveillance, market surveillance, and vigilance.
Each of these areas has requirements that flow down to the device. For example, each one of your Article 120 devices will need a PMS Plan.
There is a requirement to register economic operators. You will need to identify the economic operators and implement the MDR requirements. This includes the supplier management system under Article 10(9)(d).
There is a requirement to register the devices. While the UDI system is waived until the specific dates, you will need to assign a Basic UDI-DI as part of the registration process. You will also need to collect other information on each Article 120 device. This is also pre-market.
On the device side you will need to maintain the MDD technical documentation, but you will need to add the specific device requirements that flow from the MDR portion of the QMS. For example, each device will need an Article 88 trend reporting system. While this is typically post-market, your Article 120 devices are already in the post-market phase based on the MDD DoC & CE Mark.
You need to discuss all of this with you MDD NB, since their rules govern. Not all MDD NBs take the same approach on the details.
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
------------------------------
Original Message:
Sent: 19-Jul-2019 03:57
From: Anonymous Member
Subject: EU MDD or MDR
This message was posted by a user wishing to remain anonymous
Dan,
Does the MDR QMS need to be implemented by May 2020. I can see the PMS, Market surveillance, etc. requirements obviously apply, but surely the other QMS requirements can be implemented in line with MDR product submissions if there is no NPD or significant changes.
Original Message:
Sent: 18-Jul-2019 15:39
From: Dan O'Leary
Subject: EU MDD or MDR
Jon,
That is exactly what I mean. Assume you used MDD Annex II. Then you would have implemented EN ISO 13485:2016/AC2018, Annex ZB, Table ZB.1. The table is about two pages.
When you get to the MDR, you will implement a QMS that satisfies Article 10(9). There are about 15 requirements for the QMS, many of which are not in EN ISO 13485:2016/AC2018. To understand the differences, you should look at CEN/TR 17223:2018. Table 1 explains the requirements and shows the areas not covered by ISO 13485:2016. It is about 36 pages long.
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
Original Message:
Sent: 18-Jul-2019 14:30
From: Jon Cook
Subject: EU MDD or MDR
Hi Dan,
Can you elaborate on this statement: "Worse, you would need to undo the MDD QMS and technical documentation and redo it for the MDR. They are so different, a simple gap analysis with minor adjustments is not sufficient."
Do you mean that the QMS that is currently MDD compliant will require a complete overhaul in order to be compliant to the MDR?
Thanks
Jon
------------------------------
Jon Cook
San Jose CA
United States
Original Message:
Sent: 13-Jul-2019 19:58
From: Dan O'Leary
Subject: EU MDD or MDR
In my opinion, the only viable option is the MDR. Trying to get a CE Mark under the MDD and then using the Article 120 soft transition is far too much work. You would need to implement the MDD and have an MDD audit (devices and QMS). Then under the Article 120 transition you would need another audit for the hybrid QMS required under Article 120. The good news is that you would have time to develop a full MDR QMS and Full MDR technical documentation. The bad news is that you would need an MDD NB that plans to become an MDR NB and has the capacity to take on a new client. I doubt there are any.
Worse, you would need to undo the MDD QMS and technical documentation and redo it for the MDR. They are so different, a simple gap analysis with minor adjustments is not sufficient.
Leonard Eisner said, "you should make sure the NBs you are talking to have Designation for the type of devices you design & manufacture". This is excellent advice. I my courses I find that people don't know what this means or how to answer the question.
First, under both the MDD and the MDR, an NB is not necessarily notified for the whole directive or regulation, only parts for which they apply and can demonstrate competence. The parts use sets of codes which are not the same for the MDD and the MDR. (Under the MDD these codes form part of the basis for NB sampling plans for certain device classes.)
The list of NBs is at the NANDO website http://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.main Use caution, because a Google search for NANDO will take you to a large restaurant chain!
The page has the legislation that requires an NB. Scroll down to "Regulation (EU) 2017/745 on medical devices" and open the hyperlink. Today, you will find two organizations listed. (Some day, this will be a longer list.) Click on, for example, "TÜV SÜD Product Service GmbH Zertifizierstellen" and you will get a list of the regulations for which this company is an NB. Click on the PDF link associated with "Regulation (EU) 2017/745 on medical devices" and you will get a multi-page document. It has two lists of codes: "Codes Reflecting the Design and Intended Purpose of the Device" and "Horizontal Technical Competence". If your device isn't in a Combination of the Two (which is also a great Janis Joplin song), then the NB must reject any application you submit. Clearly you can ask them in advance.
In short, start with the MDR. It is a lot of work by itself, but, as I said, is the path that requires the least resources and has the best opportunity for success.
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
Original Message:
Sent: 13-Jul-2019 15:26
From: Leonard Eisner
Subject: EU MDD or MDR
Also you should make sure the NBs you are talking to have Designation for the type of devices you design & manufacture. There are only 2 Designated NBs (BSI & TUV SUD) and if you select an NB that isn't Designated to the MDR find out the timelines and then add a buffer os at least several months. I know that NB Designation is taking longer than anticipated even for the big players and the smaller ones it seems like you need to expect 6 - 9 months longer than original expectations as the system seems backlogged currently.
------------------------------
Leonard (Leo) Eisner, P.E.
The "IEC 60601 Guy"
Principal Consultant, Eisner Safety Consultants
Phone: (503) 244-6151
Mobile: (503) 709-8328
Email: Leo@EisnerSafety.com
Website: www.EisnerSafety.com
Original Message:
Sent: 12-Jul-2019 13:24
From: Jo Huang
Subject: EU MDD or MDR
Kindly refer to discussions in a similar thread here https://connect.raps.org/communities/community-home/digestviewer/viewthread?GroupId=97&MessageKey=d250400d-8317-42e9-8936-d7fd236347b3&CommunityKey=5af348a7-851e-4594-b467-d4d0983b6d89&tab=digestviewer&ReturnUrl=%2fcommunities%2fcommunity-home%2fdigestviewer%3fcommunitykey%3d5af348a7-851e-4594-b467-d4d0983b6d89%26tab%3ddigestviewer#bmd250400d-8317-42e9-8936-d7fd236347b3
------------------------------
Jo Huang RAC
Sr. Regulatory Affairs Specialist
Athens TX
United States
Original Message:
Sent: 11-Jul-2019 14:17
From: Anonymous Member
Subject: EU MDD or MDR
This message was posted by a user wishing to remain anonymous
Hello everyone,
For a company that has never been certified to MDD or MDR (in other words, entering the EU market for the first time), and the device is currently classfied as roughly Class IIb, does it make sense to go straight for MDR in 2020/2021 or certified to MDD and be ready for MDR in 2024? I understand there is a soft transition until 2024 for devices that are still CE marked under the MDD. Do notified bodies still conduct audits under the MDD? I would like to hear some insights.
Thanks.